{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:36:41Z","timestamp":1772159801366,"version":"3.50.1"},"reference-count":96,"publisher":"Elsevier","isbn-type":[{"value":"9780443223945","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.pbr.2023.05.001","type":"book-chapter","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T16:10:26Z","timestamp":1687623026000},"page":"149-173","source":"Crossref","is-referenced-by-count":5,"title":["Migraine and treatment-resistant depression"],"prefix":"10.1016","author":[{"given":"Shih-Pin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.pbr.2023.05.001_bb0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12967-021-02801-w","article-title":"High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis","volume":"19","author":"Affatato","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0015","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.0b013e3182824e66","article-title":"A randomized controlled trial of intranasal ketamine in migraine with prolonged aura","volume":"80","author":"Afridi","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0020","doi-asserted-by":"crossref","first-page":"e2038","DOI":"10.1212\/WNL.0000000000007371","article-title":"Imaging of neuroinflammation in migraine with aura: a [11C] PBR28 PET\/MRI study","volume":"92","author":"Albrecht","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0025","doi-asserted-by":"crossref","DOI":"10.1177\/03331024221136286","article-title":"Prolactin in headache and migraine: a systematic review of clinical studies","volume":"43","author":"Al-Karagholi","year":"2023","journal-title":"Cephalalgia"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0030","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jad.2022.09.011","article-title":"Understanding treatment-resistant depression using \u201comics\u201d techniques: a systematic review","volume":"318","author":"Amasi-Hartoonian","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40211-018-0299-5","article-title":"Migraine headache and depression in adults: a systematic review and Meta-analysis","volume":"33","author":"Amiri","year":"2019","journal-title":"Neuropsychiatr."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0040","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.euroneuro.2012.09.002","article-title":"Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder","volume":"23","author":"Amital","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0045","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1093\/brain\/aww118","article-title":"Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine","volume":"139","author":"Andreou","year":"2016","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0050","article-title":"Analysis of shared heritability in common disorders of the brain","volume":"360","author":"Anttila","year":"2018","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0055","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10194-012-0479-9","article-title":"Depression and risk of transformation of episodic to chronic migraine","volume":"13","author":"Ashina","year":"2012","journal-title":"J. Headache Pain"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0060","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial","volume":"30","author":"Aurora","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0065","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ana.26070","article-title":"Meningeal CGRP-prolactin interaction evokes female-specific migraine behavior","volume":"89","author":"Avona","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0070","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/brain\/awab267","article-title":"Dissecting the shared genetic basis of migraine and mental disorders using novel statistical tools","volume":"145","author":"Bahrami","year":"2022","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0075","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.1038\/s41380-021-01258-z","article-title":"Transcriptomic signatures of psychomotor slowing in peripheral blood of depressed patients: evidence for immunometabolic reprogramming","volume":"26","author":"Bekhbat","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jnnp-2018-319290","article-title":"Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety","volume":"90","author":"Blumenfeld","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0085","article-title":"Vagus nerve stimulation (VNS) therapy in patients with treatment resistant depression: a systematic review and meta-analysis","volume":"98","author":"Bottomley","year":"2019","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0090","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1212\/01.WNL.0000058907.41080.54","article-title":"Comorbidity of migraine and depression: investigating potential etiology and prognosis","volume":"60","author":"Breslau","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0095","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jcma.2015.10.008","article-title":"Efficacy of continuous theta burst stimulation of the primary motor cortex in reducing migraine frequency: a preliminary open-label study","volume":"79","author":"Chen","year":"2016","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0100","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/j.pain.0000000000000437","article-title":"Vagus nerve stimulation inhibits cortical spreading depression","volume":"157","author":"Chen","year":"2016","journal-title":"Pain"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0105","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1093\/brain\/awx085","article-title":"Inhibition of the P2X7-PANX1 complex suppresses spreading depolarization and neuroinflammation","volume":"140","author":"Chen","year":"2017","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.psychres.2018.08.078","article-title":"Rapid inflammation modulation and antidepressant efficacy of a low-dose ketamine infusion in treatment-resistant depression: a randomized, double-blind control study","volume":"269","author":"Chen","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jad.2019.08.022","article-title":"Antidepressant and antisuicidal effects of ketamine on the functional connectivity of prefrontal cortex-related circuits in treatment-resistant depression: a double-blind, placebo-controlled, randomized, longitudinal resting fMRI study","volume":"259","author":"Chen","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0120","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ygeno.2020.12.030","article-title":"Treatment response to low-dose ketamine infusion for treatment-resistant depression: a gene-based genome-wide association study","volume":"113","author":"Chen","year":"2021","journal-title":"Genomics"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0125","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jad.2020.10.056","article-title":"Bidirectional association between migraine and depression among probands and unaffected siblings: a nationwide population-based study","volume":"279","author":"Chen","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0130","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awad045","article-title":"Neuronal NLRP3 inflammasome mediates spreading depolarization-evoked trigeminovascular activation","author":"Chen","year":"2023","journal-title":"Brain"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s10194-022-01401-3","article-title":"Effectiveness and acceptability of noninvasive brain and nerve stimulation techniques for migraine prophylaxis: a network meta-analysis of randomized controlled trials","volume":"23","author":"Cheng","year":"2022","journal-title":"J. Headache Pain"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0145","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41582-019-0275-0","article-title":"CGRP-targeted antibodies in difficult-to-treat migraine","volume":"15","author":"De Vries","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0150","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0155","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1177\/0333102419876920","article-title":"Non-invasive vagus nerve stimulation (nVNS) for the preventive treatment of episodic migraine: the multicentre, double-blind, randomised, sham-controlled PREMIUM trial","volume":"39","author":"Diener","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0160","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ana.21779","article-title":"Androgenic suppression of spreading depression in familial hemiplegic migraine type 1 mutant mice","volume":"66","author":"Eikermann-Haerter","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0165","first-page":"99","article-title":"Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1","volume":"119","author":"Eikermann-Haerter","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0170","doi-asserted-by":"crossref","first-page":"952","DOI":"10.5811\/westjem.2018.8.37875","article-title":"Low-dose ketamine does not improve migraine in the emergency department: a randomized placebo-controlled trial","volume":"19","author":"Etchison","year":"2018","journal-title":"West. J. Emerg. Med."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0175","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/ner.13366","article-title":"Transcutaneous vagal nerve stimulation in treatment-resistant depression: a feasibility study","volume":"25","author":"Evensen","year":"2022","journal-title":"Neuromodulation"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neulet.2017.03.034","article-title":"Basal prolactin levels in rat plasma correlates with response to antidepressant treatment in animal model of depression","volume":"647","author":"Faron-G\u00f3recka","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0185","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/ijnp\/pyaa035","article-title":"Clinical correlates and outcome of major depressive disorder and comorbid migraine: a report of the European Group for the Study of resistant depression","volume":"23","author":"Fugger","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0190","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0195","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s10194-022-01388-x","article-title":"The bidirectional temporal relationship between headache and affective disorders: longitudinal data from the HUNT studies","volume":"23","author":"Giri","year":"2022","journal-title":"J. Headache Pain"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0200","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1212\/WNL.0b013e318295d69e","article-title":"Migraine, depression, and brain volume: the AGES-Reykjavik study","volume":"80","author":"Gudmundsson","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0205","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1590\/1516-4446-2020-0650","article-title":"Prevalence and correlates of major depressive disorder: a systematic review","volume":"42","author":"Guti\u00a2Rrez-Rojas","year":"2020","journal-title":"Braz. J. Psychiat."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0210","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","article-title":"Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder","volume":"49","author":"Haapakoski","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0215","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/ana.25731","article-title":"Extra-axial inflammatory signal in parameninges in migraine with visual aura","volume":"87","author":"Hadjikhani","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109908","article-title":"Antcin K targets NLRP3 to suppress neuroinflammation and improve the neurological behaviors of mice with depression","volume":"117","author":"Han","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0225","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"The international classification of headache disorders, 3rd edition","volume":"38","author":"Headache Classification Committee Of The International Headache Society","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120171","article-title":"Vagus nerve stimulation: an update on a novel treatment for treatment-resistant depression","volume":"434","author":"Kamel","year":"2022","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0240","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1126\/science.1231897","article-title":"Spreading depression triggers headache by activating neuronal Panx1 channels","volume":"339","author":"Karatas","year":"2013","journal-title":"Science"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0245","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.55.1.139","article-title":"Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine","volume":"55","author":"Kaube","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0250","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07455","article-title":"The molecular neurobiology of depression","volume":"455","author":"Krishnan","year":"2008","journal-title":"Nature"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0255","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neubiorev.2020.05.001","article-title":"Comparison of bacterial lipopolysaccharide-induced sickness behavior in rodents and humans: relevance for symptoms of anxiety and depression","volume":"115","author":"Lasselin","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0260","doi-asserted-by":"crossref","DOI":"10.1007\/s10072-023-06683-2","article-title":"Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study","author":"Lee","year":"2023","journal-title":"Neurol. Sci."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0265","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1526-4610.2010.01774.x","article-title":"A diffusion tensor magnetic resonance imaging study of corpus callosum from adult patients with migraine complicated with depressive\/anxious disorder","volume":"51","author":"Li","year":"2011","journal-title":"Headache"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0270","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/hbm.23085","article-title":"The effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: a randomized controlled study","volume":"37","author":"Li","year":"2016","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0275","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41398-020-01035-6","article-title":"Genome-wide association studies of antidepressant class response and treatment-resistant depression","volume":"10","author":"Li","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0280","doi-asserted-by":"crossref","first-page":"12649","DOI":"10.1038\/s41598-020-69291-6","article-title":"Genome-wide association study and polygenic risk score analysis of esketamine treatment response","volume":"10","author":"Li","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0285","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jad.2021.03.019","article-title":"Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression: a network meta-analysis of randomized controlled trials","volume":"287","author":"Li","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0290","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jad.2022.05.107","article-title":"Cortical excitatory and inhibitory correlates of the fronto-limbic circuit in major depression and differential effects of left frontal brain stimulation in a randomized sham-controlled trial","volume":"311","author":"Li","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0295","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/j.1526-4610.2010.01705.x","article-title":"The shared genetics of migraine and anxious depression","volume":"50","author":"Ligthart","year":"2010","journal-title":"Headache"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0300","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00439-013-1370-8","article-title":"Genetic risk score analysis indicates migraine with and without comorbid depression are genetically different disorders","volume":"133","author":"Ligthart","year":"2014","journal-title":"Hum. Genet."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2021.12.021","article-title":"The underestimated sex: a review on female animal models of depression","volume":"133","author":"Lima","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0310","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1474-4422(10)70054-5","article-title":"Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial","volume":"9","author":"Lipton","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0315","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/head.14097","article-title":"Effects of fremanezumab in patients with chronic migraine and comorbid depression: subgroup analysis of the randomized HALO CM study","volume":"61","author":"Lipton","year":"2021","journal-title":"Headache"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0320","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/0333102414557048","article-title":"Increased myo-inositol level in dorsolateral prefrontal cortex in migraine patients with major depression","volume":"35","author":"Lirng","year":"2015","journal-title":"Cephalalgia"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0325","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s10194-022-01384-1","article-title":"Efficacy profile of noninvasive vagus nerve stimulation on cortical spreading depression susceptibility and the tissue response in a rat model","volume":"23","author":"Liu","year":"2022","journal-title":"J. Headache Pain"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0330","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s10194-018-0876-9","article-title":"Exploration of intrinsic brain activity in migraine with and without comorbid depression","volume":"19","author":"Ma","year":"2018","journal-title":"J. Headache Pain"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0335","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1526-4610.2006.00309.x","article-title":"Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis--part I","volume":"46","author":"Martin","year":"2006","journal-title":"Headache"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0340","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1526-4610.2011.02036.x","article-title":"A population-based longitudinal community study of major depression and migraine","volume":"52","author":"Modgill","year":"2012","journal-title":"Headache"},{"issue":"7","key":"10.1016\/bs.pbr.2023.05.001_bb0345","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/j.pain.0000000000001856","article-title":"Vagus nerve stimulation inhibits cortical spreading depression exclusively through central mechanisms","volume":"161","author":"Morais","year":"2020","journal-title":"Pain"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0350","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-0447.1981.tb00758.x","article-title":"Bromocriptine treatment of depressive disorders. Clinical and biochemical effects","volume":"64","author":"Nordin","year":"1981","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0355","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11916-009-0066-1","article-title":"The associations between migraine, unipolar psychiatric comorbidities, and stress-related disorders and the role of estrogen","volume":"13","author":"Peterlin","year":"2009","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261477","article-title":"A replication study separates polymorphisms behind migraine with and without depression","volume":"16","author":"Petschner","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0365","article-title":"Efficacy and safety of botulinum toxin vs. placebo in depression: a systematic review and Meta-analysis of randomized controlled trials","volume":"11","author":"Qian","year":"2020","journal-title":"Front. Psych."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0370","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1468-2982.2005.00910.x","article-title":"Psychiatric comorbidity in the evolution from migraine to medication overuse headache","volume":"25","author":"Radat","year":"2005","journal-title":"Cephalalgia"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0375","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s10194-023-01552-x","article-title":"Clinical evaluation of super-responders vs. non-responders to CGRP(\u2212receptor) monoclonal antibodies: a real-world experience","volume":"24","author":"Raffaelli","year":"2023","journal-title":"J. Headache Pain"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0380","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10072-016-2568-z","article-title":"The use of onabotulinum toxin a (Botox(\u00ae)) in the treatment of chronic migraine at the Parma headache Centre: a prospective observational study","volume":"37","author":"Russo","year":"2016","journal-title":"Neurol. Sci."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0385","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/j.1526-4610.2009.01425.x","article-title":"A twin study of depression and migraine: evidence for a shared genetic vulnerability","volume":"49","author":"Schur","year":"2009","journal-title":"Headache"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0390","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41380-021-01381-x","article-title":"A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials","volume":"27","author":"Sforzini","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0395","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1212\/WNL.0000000000002918","article-title":"Chronic migraine headache prevention with noninvasive vagus nerve stimulation: the EVENT study","volume":"87","author":"Silberstein","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0400","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s10194-022-01436-6","article-title":"Galcanezumab effect on \u201cwhole pain burden\u201d and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience","volume":"23","author":"Silvestro","year":"2022","journal-title":"J. Headache Pain"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0405","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/head.13970","article-title":"Efficacy of Galcanezumab for migraine prevention in patients with a medical history of anxiety and\/or depression: a post hoc analysis of the phase 3, randomized, double-blind, placebo-controlled REGAIN, and pooled EVOLVE-1 and EVOLVE-2 studies","volume":"60","author":"Smitherman","year":"2020","journal-title":"Headache"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0410","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1212\/WNL.0b013e3181cbcd19","article-title":"Shared genetic factors in migraine and depression: evidence from a genetic isolate","volume":"74","author":"Stam","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0415","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1468-2982.2008.01666.x","article-title":"Cumulative lifetime migraine incidence in women and men","volume":"28","author":"Stewart","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0420","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.pbr.2020.05.009","article-title":"Therapeutic implications of cortical spreading depression models in migraine","volume":"255","author":"Takizawa","year":"2020","journal-title":"Prog. Brain Res."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0425","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s10194-019-1011-2","article-title":"Hypoechogenicity of brainstem raphe correlates with depression in migraine patients","volume":"20","author":"Tao","year":"2019","journal-title":"J. Headache Pain"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0430","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1212\/WNL.0000000000005857","article-title":"Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study","volume":"91","author":"Tassorelli","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0435","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40263-023-00989-7","article-title":"Cytokine- and vascular endothelial growth factor-related gene-based genome-wide association study of low-dose ketamine infusion in patients with treatment-resistant depression","volume":"37","author":"Tsai","year":"2023","journal-title":"CNS Drugs"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0440","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jad.2022.01.047","article-title":"Safety of transcranial magnetic stimulation in unipolar depression: a systematic review and meta-analysis of randomized-controlled trials","volume":"301","author":"Wang","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0445","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a039198","article-title":"Sex differences in major depressive disorder (MDD) and preclinical animal models for the study of depression","volume":"14","author":"Williams","year":"2022","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0450","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/0333102419883355","article-title":"Predictors of episodic migraine transformation to chronic migraine: a systematic review and meta-analysis of observational cohort studies","volume":"40","author":"Xu","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0455","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1017\/thg.2016.43","article-title":"Familial aggregation of migraine and depression: insights from a large Australian twin sample","volume":"19","author":"Yang","year":"2016","journal-title":"Twin Res. Hum. Genet."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0460","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jad.2019.07.045","article-title":"Inflammatory markers and treatment outcome in treatment resistant depression: a systematic review","volume":"257","author":"Yang","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0465","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.21037\/qims-21-667","article-title":"Identifying functional brain abnormalities in migraine and depression comorbidity","volume":"12","author":"Yang","year":"2022","journal-title":"Quant. Imaging Med. Surg."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0470","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/nbm.2924","article-title":"White matter integrity affected by depressive symptoms in migraine without aura: a tract-based spatial statistics study","volume":"26","author":"Yu","year":"2013","journal-title":"NMR Biomed."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0475","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/bs.pbr.2023.05.001_bb0480","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13699","article-title":"The prevalence and National Burden of treatment-resistant depression and major depressive disorder in the United States","volume":"82","author":"Zhdanava","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/bs.pbr.2023.05.001_bb0485","doi-asserted-by":"crossref","first-page":"1050090","DOI":"10.3389\/fneur.2022.1050090","article-title":"Efficacy of repetitive transcranial magnetic stimulation on chronic migraine: a meta-analysis","volume":"13","author":"Zhong","year":"2022","journal-title":"Front. Neurol."}],"container-title":["Progress in Brain Research","Treatment-Resistant Depression Part B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612323000456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612323000456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T12:09:02Z","timestamp":1696594142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612323000456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780443223945"],"references-count":96,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2023.05.001","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}